Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pier Giovanni Baraldi

Showing results (21-30 of 159) with videos related to

Pageof 16
Sort By:
Medicinal Research Reviews|December 16, 2016
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor AntagonistsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Stefania Baraldi, et al.
Current Medicinal Chemistry|December 16, 2006
Ligands for A2B adenosine receptor subtypePier Giovanni Baraldi, Romeo Romagnoli, Delia Preti, et al.
European Journal of Medicinal Chemistry|October 12, 2010
Synthesis and biological evaluation of 2-(3',4',5'-trimethoxybenzoyl)-3-aryl/arylaminobenzo[b]thiophene derivatives as a novel class of antiproliferative agentsRomeo Romagnoli, Pier Giovanni Baraldi, Carlota Lopez Cara, et al.
Journal of Medicinal Chemistry|November 24, 2005
Design, synthesis, and biological evaluation of hybrid molecules containing alpha-methylene-gamma-butyrolactones and alpha-bromoacryloyl moietiesRomeo Romagnoli, Pier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, et al.
Journal of Medicinal Chemistry|April 4, 2003
Synthesis and biological activity of N-arylpiperazine-modified analogues of KN-62, a potent antagonist of the purinergic P2X7 receptorPier Giovanni Baraldi, Maria del Carmen Nuñez, Anna Morelli, et al.
Journal of Medicinal Chemistry|April 30, 2004
Cytotoxic alpha-halogenoacrylic derivatives of distamycin A and congenersItalo Beria, Pier Giovanni Baraldi, Paolo Cozzi, et al.
Purinergic Signalling|April 12, 2008
Novel selective antagonist radioligands for the pharmacological study of A(2B) adenosine receptorsStefania Gessi, Katia Varani, Stefania Merighi, et al.
Pharmacological Reviews|November 13, 2014
The A3 adenosine receptor: history and perspectivesPier Andrea Borea, Katia Varani, Fabrizio Vincenzi, et al.
Biochemical Pharmacology|February 14, 2002
Binding thermodynamics at the human A(3) adenosine receptorStefania Merighi, Katia Varani, Stefania Gessi, et al.
Medicinal Research Reviews|June 2, 2004
DNA minor groove binders as potential antitumor and antimicrobial agentsPier Giovanni Baraldi, Andrea Bovero, Francesca Fruttarolo, et al.
Pageof 16

Showing results (21-30 of 159) with videos related to

Sort By:
Pageof 16
Medicinal Research Reviews|December 16, 2016
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor AntagonistsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Stefania Baraldi, et al.
Current Medicinal Chemistry|December 16, 2006
Ligands for A2B adenosine receptor subtypePier Giovanni Baraldi, Romeo Romagnoli, Delia Preti, et al.
European Journal of Medicinal Chemistry|October 12, 2010
Synthesis and biological evaluation of 2-(3',4',5'-trimethoxybenzoyl)-3-aryl/arylaminobenzo[b]thiophene derivatives as a novel class of antiproliferative agentsRomeo Romagnoli, Pier Giovanni Baraldi, Carlota Lopez Cara, et al.
Journal of Medicinal Chemistry|November 24, 2005
Design, synthesis, and biological evaluation of hybrid molecules containing alpha-methylene-gamma-butyrolactones and alpha-bromoacryloyl moietiesRomeo Romagnoli, Pier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, et al.
Journal of Medicinal Chemistry|April 4, 2003
Synthesis and biological activity of N-arylpiperazine-modified analogues of KN-62, a potent antagonist of the purinergic P2X7 receptorPier Giovanni Baraldi, Maria del Carmen Nuñez, Anna Morelli, et al.
Journal of Medicinal Chemistry|April 30, 2004
Cytotoxic alpha-halogenoacrylic derivatives of distamycin A and congenersItalo Beria, Pier Giovanni Baraldi, Paolo Cozzi, et al.
Purinergic Signalling|April 12, 2008
Novel selective antagonist radioligands for the pharmacological study of A(2B) adenosine receptorsStefania Gessi, Katia Varani, Stefania Merighi, et al.
Pharmacological Reviews|November 13, 2014
The A3 adenosine receptor: history and perspectivesPier Andrea Borea, Katia Varani, Fabrizio Vincenzi, et al.
Biochemical Pharmacology|February 14, 2002
Binding thermodynamics at the human A(3) adenosine receptorStefania Merighi, Katia Varani, Stefania Gessi, et al.
Medicinal Research Reviews|June 2, 2004
DNA minor groove binders as potential antitumor and antimicrobial agentsPier Giovanni Baraldi, Andrea Bovero, Francesca Fruttarolo, et al.
Pageof 16